Pages that link to "Item:Q1596008"

The following pages link to Statistical approaches to interim monitoring of medical trials: A review and commentary (Q1596008):

Displaying 20 items.

• Comparison of conditional power criteria for early termination of clinical trials (Q956934) (← links)
• Type I error probability spending for post-market drug and vaccine safety surveillance with Poisson data (Q1657816) (← links)
• Odds ratio-based group sequential analysis for joint binomial and inverse binomial sampling (Q2816633) (← links)
• Interim analysis of clinical trials based on urn models (Q2856557) (← links)
• (Q4003496) (← links)
• Some topics of current interest in clinical trials (Q4018593) (← links)
• On the curtailment of sampling (Q4024613) (← links)
• Incorporation of a stopping criterion for futility into the design of a clinical trial with one interim analysis (Q4226911) (← links)
• Approximations for non-symmetric truncated sequential and repeated significance tests (Q4254240) (← links)
• ESTIMATION FOLLOWING EXTENSION OF A STUDY ON THE BASIS OF CONDITIONAL POWER (Q4512838) (← links)
• Testing Secondary Hypotheses Following Sequential Clinical Trials (Q4667496) (← links)
• CONDITIONAL PROBABILITY OF SIGNIFICANCE FOR EARLY STOPPING IN FAVOR OF<i>H</i>₀ (Q4787882) (← links)
• Three-stage designs for monitoring clinical trials (Q4843696) (← links)
• Sequential design and analysis in the randomized clinical trial: A historical perspective (Q4965649) (← links)
• Bayesian Inference Is Unaffected by Selection: Fact or Fiction? (Q5050792) (← links)
• (Q5158694) (← links)
• Finding confidence bound using two-stage data (Q5160236) (← links)
• Alpha spending for historical versus surveillance Poisson data with CMaxSPRT (Q6625629) (← links)
• Exact sequential analysis for multiple weighted binomial end points (Q6627307) (← links)
• Exact sequential test for clinical trials and post-market drug and vaccine safety surveillance with Poisson and binary data (Q6627990) (← links)